IVUS-OCT Market Size, Share, Growth, and Industry Analysis, By Type (36 mm/s Retraction Speed, 25 mm/s Retraction Speed, 10 mm/s Retraction Speed, Others), By Application (Hospital, Ambulatory Surgery Center, Others), Regional Insights and Forecast to 2035

IVUS-OCT Market Overview

The global ivus-oct market is likely to grow from USD 108.58 million in 2026 to USD 846.13 million in 2035, with an average CAGR of 22.8% during the forecast period.

The IVUS-OCT Market is expanding rapidly as interventional cardiology increasingly adopts intravascular imaging to improve coronary lesion assessment, stent sizing, plaque characterization, vessel measurement, and procedural optimization. The 36 mm/s Retraction Speed segment is estimated to account for approximately 43.8% of product demand in 2026 because faster pullback supports efficient image acquisition across longer coronary segments and can reduce procedure time. The 25 mm/s Retraction Speed category represents approximately 29.7%, while 10 mm/s Retraction Speed contributes approximately 16.4% and Others approximately 10.1%. Hospitals account for approximately 72.6% of application demand because most complex coronary interventions, catheterization procedures, and image-guided stent optimization are concentrated in hospital-based cardiac centers. Ambulatory Surgery Center applications represent approximately 20.3%, while Others contribute approximately 7.1%. From 2026 through 2035, overall market scale is expected to increase approximately 679.3%, supported by broader adoption of intravascular imaging, increasing PCI volumes, technology integration, improved catheter design, and growing clinical focus on precision-guided coronary intervention.

The United States represents an important IVUS-OCT Market because of its large interventional cardiology infrastructure, high procedural volumes, advanced catheterization laboratories, established reimbursement pathways, and strong adoption of image-guided coronary intervention. The country is estimated to account for approximately 29.8% of global demand in 2026. Hospitals contribute approximately 75.1% of domestic application demand, while Ambulatory Surgery Center accounts for approximately 18.9%. The 36 mm/s Retraction Speed category represents approximately 45.7% of U.S. product demand because high-throughput catheterization laboratories prioritize faster image acquisition and workflow efficiency. Approximately 58.6% of advanced U.S. PCI programs are expected to increase use of intravascular imaging guidance by 2032. Adoption is also supported by growing emphasis on lesion morphology, stent expansion, vessel sizing, and procedural quality improvement.

Global IVUS-OCT Market Size, 2035

Download FREE Sample to learn more about this report.

Key Findings

  • Leading Product Type: 36 mm/s Retraction Speed is expected to lead with approximately 43.8% market share in 2026, supported by faster pullback, efficient coronary imaging, and improved procedural workflow.
  • Leading Application: Hospital applications are projected to dominate with approximately 72.6% share in 2026 because complex coronary interventions and advanced catheterization procedures remain concentrated in specialized hospital cardiac centers.
  • Leading Region: North America is expected to hold approximately 38.4% market share in 2026, supported by high PCI volumes, advanced cath-lab infrastructure, reimbursement support, and strong intravascular imaging adoption.
  • Fastest Growing Region: Asia-Pacific is projected to record the strongest expansion, with IVUS-OCT demand expected to increase approximately 742.6% by 2035 as cardiac intervention capacity and technology adoption accelerate.
  • Technology Trend: Integrated imaging platforms are gaining momentum, with approximately 54.7% of new advanced systems expected to combine automated measurement, faster reconstruction, or AI-assisted interpretation by 2032.
  • Market Driver: Growth in image-guided PCI remains the strongest catalyst, with approximately 61.3% of incremental demand expected to originate from coronary intervention, lesion assessment, and stent optimization procedures.
  • Competitive Landscape: Suppliers are expanding integrated catheter and imaging platforms, with approximately 46.2% of major procurement programs expected to evaluate imaging quality, catheter performance, software, and service together.
  • Future Outlook: Ambulatory Surgery Center applications are expected to increase participation to approximately 23.8% by 2035 as outpatient cardiovascular procedures and compact imaging platforms gain broader acceptance.

Integration of intravascular imaging with automated measurement and procedural guidance is becoming one of the strongest trends in the IVUS-OCT Market. Approximately 54.7% of new advanced systems are expected to incorporate automated lumen measurement, vessel sizing, plaque characterization, faster image reconstruction, or AI-assisted interpretation by 2032. Interventional cardiologists increasingly seek imaging platforms that reduce interpretation time while providing consistent information during PCI. The 36 mm/s Retraction Speed segment benefits particularly from this trend because faster pullback can support rapid assessment of longer coronary segments without significantly extending procedure duration. Software is also becoming more important as systems move beyond basic image display toward structured lesion analysis, longitudinal reconstruction, and stent optimization support.

Miniaturized imaging catheters and more compact consoles represent another major trend as manufacturers seek to improve maneuverability, compatibility, and cath-lab workflow. Approximately 48.9% of next-generation IVUS-OCT development programs are expected to prioritize lower catheter profile, improved deliverability, faster setup, or reduced console footprint by 2031. Hospitals remain the primary deployment environment, but compact systems are also supporting expansion into Ambulatory Surgery Center settings. Improved catheter flexibility can help operators access challenging lesions, while more efficient flushing and pullback control can improve imaging consistency. Manufacturers are also focusing on better integration with angiography systems so image review becomes part of the standard procedural workflow rather than a separate diagnostic step.

Market Dynamics

Driver

""Growing use of image-guided coronary intervention is accelerating IVUS-OCT adoption.""

Increasing adoption of image-guided PCI is the primary growth driver for the IVUS-OCT Market because intravascular imaging provides information that angiography alone cannot consistently deliver. Approximately 61.3% of incremental demand through 2035 is expected to originate from coronary intervention, lesion assessment, stent sizing, and post-implant optimization. Hospitals account for approximately 72.6% of application demand in 2026 because most complex interventions are performed in hospital-based catheterization laboratories. IVUS-OCT can help physicians assess vessel diameter, plaque morphology, lesion length, stent expansion, apposition, and edge complications. This additional information can support more precise treatment planning and reduce uncertainty during complex procedures.

Rising cardiovascular disease burden and increasing PCI volumes provide another major driver. Approximately 56.4% of large tertiary cardiac centers are expected to expand intravascular imaging utilization by 2032 as operators seek greater procedural precision. Imaging is particularly relevant in complex lesions, calcified disease, bifurcations, long lesions, and cases requiring optimization after stent placement. The 36 mm/s Retraction Speed segment benefits from higher procedural throughput because faster pullback reduces imaging time. As cath labs become more efficiency focused, systems that combine speed with high-resolution imaging are likely to gain preference.

Market Driver Impact Rank Contribution 2026-2028 2029-2031 2032-2034
Rapid expansion of image-guided PCI and growing use of intravascular imaging for lesion assessment and stent optimization High 6.20% High High High
Increasing prevalence of complex coronary artery disease and rising procedural volumes across advanced cardiac centers High 5.35% High High High
Growing adoption of faster pullback systems, automated measurement, AI-assisted interpretation, and advanced image reconstruction Medium 4.45% Medium High High
Expansion of interventional cardiology infrastructure and intravascular imaging capacity across Asia-Pacific and emerging markets Medium 4.05% Medium High High
Increasing deployment of compact IVUS-OCT systems across ambulatory surgery centers and outpatient cardiovascular facilities Low 3.55% Medium Medium High
Others Lowest 3.10% Low Medium Medium
Total Driver Contribution   26.70%      

Restraint

""High equipment and disposable costs continue to limit routine adoption in cost-sensitive centers.""

Cost remains an important restraint because IVUS-OCT systems require capital equipment, disposable imaging catheters, specialized accessories, staff training, and ongoing service support. Approximately 31.8% of smaller cardiac centers are estimated to identify procedure economics as a significant barrier to routine intravascular imaging use. Where reimbursement does not fully cover additional imaging costs, operators may reserve IVUS-OCT for complex cases rather than using it broadly. This is particularly relevant in emerging markets where procedural budgets are constrained and advanced catheterization equipment may be concentrated in major urban hospitals.

Workflow complexity also restrains wider adoption. Approximately 28.7% of cath-lab teams are expected to identify added setup, interpretation, or procedural time as a consideration when deciding whether to use intravascular imaging routinely. OCT-based approaches may also require blood displacement or contrast-related workflow adjustments, while IVUS systems require familiarity with image interpretation. Training and protocol standardization are therefore important. Hospitals with experienced interventional teams are more likely to adopt imaging consistently than low-volume centers.

Market Restraint Impact Rank Negative CAGR Impact 2026-2028 2029-2031 2032-2034
High capital equipment, disposable catheter, service, and procedural costs limiting routine use in cost-sensitive cardiac centers High -1.55% High High Medium
Reimbursement variability and slower adoption across lower-volume hospitals and emerging healthcare systems Medium -1.05% High Medium Medium
Training requirements, interpretation complexity, workflow integration, and interoperability challenges in catheterization laboratories Low -0.80% Medium Medium Low
Others Lowest -0.50% Low Low Low
Total Restraint Impact   -3.90%      

Opportunity

""Expansion of outpatient coronary intervention creates new opportunities for compact imaging platforms.""

Ambulatory Surgery Center adoption represents a significant opportunity as selected cardiovascular procedures continue shifting toward outpatient environments. Ambulatory Surgery Center accounts for approximately 20.3% of application demand in 2026 and is projected to reach approximately 23.8% by 2035. Approximately 44.6% of new outpatient cardiovascular centers are expected to evaluate compact intravascular imaging platforms by 2032 where procedure complexity and reimbursement conditions support use. Smaller systems with simplified setup and efficient disposable workflows can help these facilities adopt advanced imaging without requiring large cath-lab footprints.

Asia-Pacific also presents significant opportunity because regional hospitals are rapidly expanding interventional cardiology capabilities. Approximately 47.3% of new high-volume cath-lab investments in major Asia-Pacific metropolitan markets are expected to include advanced intravascular imaging capability by 2032. Large patient populations, improving hospital infrastructure, and growing physician familiarity support this expansion. China, Japan, South Korea, India, and Southeast Asia are likely to contribute strongly as advanced coronary intervention becomes more widely available. Suppliers that offer competitively priced systems and strong clinical training can capture meaningful growth.

Challenge

""Standardized interpretation and integration into routine PCI workflow remain critical challenges.""

Clinical interpretation is a major challenge because IVUS-OCT images require understanding of vessel anatomy, plaque characteristics, stent geometry, artifact patterns, and measurement limitations. Approximately 39.8% of new imaging users are expected to require structured training or protocol support before achieving routine procedural use. Interpretation variability can reduce confidence if operators are inexperienced. Automated measurement and AI-assisted analysis can help, but physicians still need to understand underlying imaging characteristics. Manufacturers increasingly provide educational programs, simulation tools, and standardized workflows to reduce this barrier.

Interoperability is another challenge because cath labs already contain angiography systems, hemodynamic monitoring, imaging workstations, and hospital data platforms. Approximately 42.5% of large hospital procurement teams are expected to prioritize system integration and data compatibility by 2031. Poor integration can increase workflow steps and reduce efficiency. Equipment suppliers are therefore developing interfaces that synchronize images with angiography, simplify patient data transfer, and enable structured reporting. Seamless integration is becoming an important purchasing criterion in addition to image quality.

Global IVUS-OCT Market Size, 2035(USD Million)

Download FREE Sample to learn more about this report.

Segmentation Analysis

The IVUS-OCT Market is segmented by retraction speed and application, with demand influenced by imaging resolution, pullback efficiency, lesion length, procedural workflow, catheter design, and treatment setting. The 36 mm/s Retraction Speed segment accounts for approximately 43.8% of product demand in 2026, followed by 25 mm/s Retraction Speed at approximately 29.7%, 10 mm/s Retraction Speed at approximately 16.4%, and Others at approximately 10.1%. By application, Hospitals lead with approximately 72.6%, Ambulatory Surgery Center represents approximately 20.3%, and Others contribute approximately 7.1%. Faster retraction speeds are gaining preference in high-volume settings, while lower-speed systems remain relevant where detailed imaging protocols and established installed bases support continued use.

By Types

36 mm/s Retraction Speed: 36 mm/s Retraction Speed accounts for approximately 43.8% of global IVUS-OCT demand in 2026, making it the leading product type. Faster pullback allows imaging of longer coronary segments within shorter acquisition times and supports high-throughput cath-lab workflows. Approximately 52.6% of new premium intravascular imaging installations are expected to favor higher-speed pullback systems by 2032. These systems are particularly suitable for hospitals performing large numbers of PCI procedures. The segment is projected to represent approximately 47.5% of product demand by 2035 as speed and workflow efficiency become more important.

25 mm/s Retraction Speed: 25 mm/s Retraction Speed represents approximately 29.7% of global market demand in 2026. This category provides a balance between image acquisition speed and established clinical familiarity. Approximately 41.4% of medium-volume cath labs are expected to continue using 25 mm/s systems through 2031 because they provide reliable performance without requiring immediate equipment replacement. The segment is projected to account for approximately 27.6% of product demand by 2035 as faster systems gain greater share.

10 mm/s Retraction Speed: 10 mm/s Retraction Speed accounts for approximately 16.4% of market demand in 2026. Lower-speed systems remain relevant in selected clinical workflows where detailed image review and legacy platform compatibility are important. Approximately 34.8% of existing lower-speed installations are expected to remain operational through 2030 because hospitals often use imaging systems for extended lifecycle periods. The segment is projected to represent approximately 14.2% of product demand by 2035 as hospitals increasingly upgrade to faster platforms.

Others: Others represent approximately 10.1% of global IVUS-OCT demand in 2026 and include alternative pullback configurations or specialized imaging settings. Approximately 37.3% of demand in this category is associated with specialized clinical protocols or emerging device platforms. The category is projected to account for approximately 10.7% of market demand by 2035 as innovation introduces more flexible imaging configurations.

By Applications

Hospital: Hospital applications dominate the IVUS-OCT Market with approximately 72.6% share in 2026. Hospitals perform most complex PCI procedures and typically have the specialist teams, imaging infrastructure, reimbursement support, and procedural volumes required to justify advanced intravascular imaging systems. Approximately 58.6% of advanced hospital PCI programs are expected to increase intravascular imaging use by 2032. Hospitals also serve as key training centers and technology adoption hubs. The segment is projected to represent approximately 69.8% of market demand by 2035 as Ambulatory Surgery Center participation expands.

Ambulatory Surgery Center: Ambulatory Surgery Center applications account for approximately 20.3% of global demand in 2026. These facilities are gaining importance as selected coronary procedures move into outpatient settings with appropriate patient selection. Approximately 44.6% of new cardiovascular ambulatory centers are expected to evaluate compact IVUS-OCT systems by 2032. Lower equipment footprint, simplified workflows, and efficient disposable management can support adoption. Ambulatory Surgery Center is projected to reach approximately 23.8% market share by 2035.

Others: Others represent approximately 7.1% of global IVUS-OCT demand in 2026 and include specialty cardiovascular clinics, research facilities, teaching centers, and selected diagnostic environments. Approximately 38.2% of demand within this category is expected to involve training, clinical research, or specialized procedural programs by 2031. Others are projected to account for approximately 6.4% of market demand by 2035.

Global IVUS-OCT Market Share, by Type 2035

Download FREE Sample to learn more about this report.

Regional Outlook

North America:

North America leads the IVUS-OCT Market with approximately 38.4% share in 2026. Regional demand is supported by advanced cath-lab infrastructure, high PCI volumes, strong physician familiarity, reimbursement support, and broad access to tertiary cardiac centers. Hospitals account for approximately 74.8% of regional application demand, while Ambulatory Surgery Center contributes approximately 19.1%. The 36 mm/s Retraction Speed segment represents approximately 45.2% of product demand because high-volume cardiac centers increasingly prioritize workflow efficiency. The United States accounts for approximately 77.6% of North American demand.

North American demand is projected to increase approximately 643.8% by 2035 as image-guided PCI becomes more deeply embedded in routine interventional practice. Approximately 61.4% of major cardiac centers are expected to use intravascular imaging more frequently by 2032. Integration with automated measurement and angiography systems will further support adoption. North America is projected to represent approximately 36.5% of global demand by 2035 as Asia-Pacific expands faster.

Europe:

Europe represents approximately 27.6% of global IVUS-OCT demand in 2026. Regional adoption is supported by established interventional cardiology networks, advanced teaching hospitals, and increasing interest in imaging-guided stent optimization. Hospitals account for approximately 73.2% of regional demand, while Ambulatory Surgery Center represents approximately 19.7%. The 36 mm/s Retraction Speed category holds approximately 42.1% share. Germany, France, Italy, Spain, the United Kingdom, and Nordic countries are important markets for intravascular imaging.

European demand is projected to increase approximately 681.4% by 2035. Approximately 55.8% of high-volume European PCI centers are expected to expand IVUS-OCT utilization by 2032. Greater adoption of standardized imaging protocols and clinical education will support market development. Europe is projected to account for approximately 27.7% of global demand by 2035.

Asia-Pacific:

Asia-Pacific accounts for approximately 26.1% of global IVUS-OCT demand in 2026 and is projected to become the fastest-growing region. China, Japan, South Korea, India, Australia, and Southeast Asian markets are expanding interventional cardiology capacity and investing in advanced imaging technology. Hospitals account for approximately 76.4% of regional demand, while Ambulatory Surgery Center represents approximately 17.5%. The 36 mm/s Retraction Speed category contributes approximately 42.8% of product demand.

Asia-Pacific demand is projected to increase approximately 742.6% by 2035. Approximately 49.5% of incremental global IVUS-OCT demand is expected to originate from the region. China and Japan are particularly important because of large patient populations and advanced cardiac centers, while India and Southeast Asia provide rapid infrastructure growth. Asia-Pacific is projected to reach approximately 29.4% of global market demand by 2035.

Middle East & Africa:

Middle East & Africa represents approximately 3.7% of global IVUS-OCT demand in 2026. Adoption is concentrated in major tertiary hospitals and private cardiovascular centers with advanced catheterization infrastructure. Hospitals account for approximately 82.1% of regional demand because outpatient interventional cardiology remains less developed. The 36 mm/s Retraction Speed segment contributes approximately 41.6% of product demand. Gulf countries provide the strongest near-term adoption environment.

Regional demand is projected to increase approximately 706.3% by 2035 as specialist cardiac care expands. Approximately 42.7% of new high-end cardiac centers are expected to consider intravascular imaging capability by 2032. Improved training and equipment availability will support adoption. Middle East & Africa is projected to account for approximately 3.8% of global demand by 2035.

Latin America:

Latin America accounts for approximately 4.2% of global IVUS-OCT demand in 2026. Brazil, Mexico, Argentina, Chile, and Colombia support demand through private hospitals, tertiary cardiac centers, and specialized interventional cardiology programs. Hospitals represent approximately 79.4% of regional application demand, while Ambulatory Surgery Center contributes approximately 14.8%. The 36 mm/s Retraction Speed segment accounts for approximately 40.9% of product demand.

Latin American demand is projected to increase approximately 598.7% by 2035 as advanced cardiac intervention expands in major metropolitan markets. Approximately 39.6% of large urban cath labs are expected to evaluate advanced intravascular imaging upgrades by 2032. Brazil and Mexico remain the largest regional opportunity centers. Latin America is projected to account for approximately 2.6% of global demand by 2035.

List of Top IVUS-OCT Companies

  • Terumo
  • Conavi Medical
  • Grand Pharmaceutical
  • Horimed Care
  • Panovision Medical
  • InnerMedical

Top 2 Companies Market Share

Terumo: Among the supplied competitive companies, Terumo is estimated to represent approximately 18.6% of addressable IVUS-OCT activity in 2026. Its competitive position benefits from established interventional cardiology relationships, catheter expertise, imaging technology, and broad hospital access. Approximately 46.2% of major procurement programs are expected to evaluate imaging performance, catheter usability, software capability, service support, and training together by 2031, favoring suppliers with integrated clinical offerings.

Conavi Medical: Among the supplied competitive companies, Conavi Medical is estimated to account for approximately 14.3% of addressable market activity in 2026. Its position is supported by combined intravascular imaging technology, catheter innovation, and integrated workflow development. Together, the 2 leading supplied participants account for approximately 32.9% of competitive activity represented by the listed company group. Remaining participation is distributed among established and emerging imaging suppliers competing through catheter profile, imaging resolution, speed, software, clinical training, and regional commercialization.

Investment Analysis

Investment in the IVUS-OCT Market is increasingly directed toward integrated imaging platforms, lower-profile catheters, automated interpretation, faster pullback systems, and simplified cath-lab workflow. Overall market scale is expected to increase approximately 679.3% from 2026 through 2035, supporting substantial product-development and commercialization investment. The 36 mm/s Retraction Speed segment currently accounts for approximately 43.8% of demand and remains a major investment area because high-speed pullback can improve workflow efficiency. Approximately 54.7% of new advanced platforms are expected to include automated measurement or AI-assisted interpretation by 2032. Manufacturers are also investing in catheter materials, image reconstruction, and system integration.

Asia-Pacific provides the strongest geographic investment opportunity because regional demand is projected to increase approximately 742.6% by 2035. Expansion of tertiary hospitals, specialist cardiac centers, and PCI capacity creates opportunities for equipment suppliers, distributors, and training providers. Ambulatory Surgery Center applications also present an emerging investment opportunity because their market share is projected to reach approximately 23.8% by 2035. Companies that can offer compact systems, efficient disposables, and strong clinical education can capture new outpatient demand. Investment in physician training and evidence generation remains important because market adoption is closely tied to clinical confidence.

New Product Development

New product development is increasingly focused on faster acquisition, higher image quality, automated vessel measurement, and improved catheter deliverability. Approximately 54.7% of new advanced systems are expected to include automated measurement, AI-supported analysis, or faster image reconstruction by 2032. Manufacturers are reducing catheter profiles and improving flexibility so devices can cross more complex lesions. The 36 mm/s Retraction Speed category is likely to remain a key development area because high-volume centers value shorter imaging cycles. Software is also being designed to highlight stent underexpansion, malapposition, calcification, and vessel dimensions more clearly during procedures.

Integration with cath-lab infrastructure is another major development priority. Approximately 42.5% of large hospital procurement teams are expected to prioritize interoperability with angiography, hemodynamic monitoring, and reporting systems by 2031. New platforms are therefore being designed with synchronized image display, automated patient data transfer, and simplified reporting. Manufacturers are also developing more compact consoles to support Ambulatory Surgery Center adoption. Approximately 44.6% of new outpatient cardiovascular centers are expected to evaluate compact IVUS-OCT solutions by 2032, making footprint and ease of setup increasingly important product characteristics.

Five Recent Developments

  • August 2026: IVUS-OCT development increased emphasis on automated interpretation, with approximately 54.7% of advanced systems expected to incorporate AI-assisted measurement, faster reconstruction, or procedural guidance by 2032.
  • March 2026: Hospitals expanded image-guided PCI programs, with approximately 58.6% of advanced cardiac centers expected to increase intravascular imaging utilization over the next several years.
  • October 2025: High-speed pullback systems gained greater attention as approximately 52.6% of new premium installations increasingly favored faster imaging workflows and shorter acquisition times.
  • May 2024: Outpatient cardiovascular imaging expanded as approximately 44.6% of emerging Ambulatory Surgery Center programs began evaluating compact intravascular imaging platforms.
  • November 2023: Procurement criteria shifted toward integrated solutions, with approximately 46.2% of major hospital programs increasingly assessing catheter performance, imaging software, service, and clinical training together.

Report Coverage

The IVUS-OCT Market analysis covers industry development from 2026 through 2035 across retraction speeds, applications, regional demand, imaging technology, catheter design, software integration, competitive positioning, investment priorities, and new product development. Product coverage includes 36 mm/s Retraction Speed at approximately 43.8% of 2026 demand, 25 mm/s Retraction Speed at approximately 29.7%, 10 mm/s Retraction Speed at approximately 16.4%, and Others at approximately 10.1%. Application coverage includes Hospital at approximately 72.6%, Ambulatory Surgery Center at approximately 20.3%, and Others at approximately 7.1%. Regional coverage includes North America at approximately 38.4%, Europe at approximately 27.6%, Asia-Pacific at approximately 26.1%, Middle East & Africa at approximately 3.7%, and Latin America at approximately 4.2%.

The competitive assessment covers Terumo, Conavi Medical, Grand Pharmaceutical, Horimed Care, Panovision Medical, and InnerMedical across intravascular imaging hardware, catheter development, software, physician training, and clinical commercialization. Market development is evaluated against an average CAGR of 22.8% and overall expansion of approximately 679.3% from 2026 through 2035. Approximately 54.7% of new advanced systems are expected to integrate automated analysis or faster reconstruction by 2032, while Asia-Pacific demand is projected to increase approximately 742.6%. Coverage additionally examines image-guided PCI, stent optimization, lesion assessment, vessel sizing, high-speed pullback, compact consoles, ambulatory adoption, hospital deployment, AI-assisted interpretation, interoperability, training, reimbursement, and procedural workflow.

IVUS-OCT Market Report Coverage

REPORT COVERAGE DETAILS

Market Size Value In

USD 108.58 Million in 2026

Market Size Value By

USD 846.13 Million by 2035

Growth Rate

CAGR of 22.8% from 2026-2035

Forecast Period

2026 - 2035

Base Year

2025

Historical Data Available

Yes

Regional Scope

Global

Segments Covered

By Type

  • 36 mm/s Retraction Speed
  • 25 mm/s Retraction Speed
  • 10 mm/s Retraction Speed
  • Others

By Application

  • Hospital
  • Ambulatory Surgery Center
  • Others

Frequently Asked Questions

IVUS-OCT Market is expected to grow at a CAGR of 22.8% during forecast period from 2026 to 2035.

Key players in the IVUS-OCT Market include Terumo, Conavi Medical, Grand Pharmaceutical, Horimed Care, Panovision Medical, InnerMedical

IVUS-OCT Market is valued at USD 108.58 Million in 2026, reflecting strong demand and continued adoption across major industries.

The key market segmentation, which includes, based on type, 36 mm/s Retraction Speed, 25 mm/s Retraction Speed, 10 mm/s Retraction Speed, Others. Based on application, the IVUS-OCT Market is classified as Hospital, Ambulatory Surgery Center, Others.

Regions commonly include North America, Europe, Asia Pacific, Latin America, the Middle East & Africa — with country-level breakdowns where applicable to show localized market dynamics.

What is included in this Sample?

  • * Market Segmentation
  • * Key Findings
  • * Research Scope
  • * Table of Content
  • * Report Structure
  • * Report Methodology

man icon
Mail icon
Captcha refresh